Jeffrey W. Jacobs, VP, Chemistry at ARDELYX, INC. (ARDX), sold 981 shares at $15.81 ($16K) on 2015-03-02, disclosed to the SEC on 2015-03-04.
Scheduled sale ($16k) by VP, Chemistry under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ARDX | SELL | 2021-11-10 | $3K | — | Filing → |
| ARDX | SELL | 2021-08-24 | $978 | — | Filing → |
| ARDX | SELL | 2021-06-17 | $55K | — | Filing → |